RA Capital Management as of Sept. 30, 2012
Portfolio Holdings for RA Capital Management
RA Capital Management holds 25 positions in its portfolio as reported in the September 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dyax | 10.5 | $22M | 8.5M | 2.60 | |
| Achillion Pharmaceuticals | 10.4 | $22M | 2.1M | 10.41 | |
| Anacor Pharmaceuticals In | 7.9 | $17M | 2.5M | 6.58 | |
| Sunesis Pharmaceuticals | 6.9 | $15M | 2.6M | 5.63 | |
| ArthroCare Corporation | 6.7 | $14M | 439k | 32.40 | |
| Derma Sciences | 6.2 | $13M | 1.3M | 10.38 | |
| Sangamo Biosciences (SGMO) | 6.1 | $13M | 2.1M | 6.08 | |
| XOMA CORP Common equity shares | 5.4 | $11M | 3.1M | 3.69 | |
| ACADIA Pharmaceuticals (ACAD) | 5.3 | $11M | 4.4M | 2.53 | |
| Insmed (INSM) | 5.3 | $11M | 2.5M | 4.55 | |
| Vanda Pharmaceuticals (VNDA) | 4.5 | $9.5M | 2.4M | 4.03 | |
| Coronado Biosciences Inc. Common | 4.4 | $9.2M | 1.8M | 5.20 | |
| OncoGenex Pharmaceuticals | 3.5 | $7.4M | 523k | 14.17 | |
| Ym Biosciences | 2.8 | $5.8M | 3.2M | 1.84 | |
| Sequenom | 2.5 | $5.3M | 1.5M | 3.53 | |
| Senomyx | 2.5 | $5.2M | 2.8M | 1.90 | |
| Verastem | 2.5 | $5.2M | 558k | 9.39 | |
| INC Ventrus Biosciences | 2.1 | $4.5M | 1.2M | 3.58 | |
| Anthera Pharmaceuticals | 1.4 | $2.9M | 2.9M | 0.99 | |
| D Tranzyme | 1.0 | $2.1M | 468k | 4.46 | |
| MELA Sciences | 0.8 | $1.6M | 500k | 3.21 | |
| ImmunoGen | 0.7 | $1.4M | 95k | 14.59 | |
| Synergy Pharmaceuticals | 0.6 | $1.2M | 259k | 4.78 | |
| D Horizon Pharma | 0.2 | $350k | 100k | 3.50 | |
| Savient Pharmaceuticals note | 0.1 | $250k | 1.0M | 0.25 |
